D-aspartate regulates melanocortin formation and function: Behavioral alterations in D-aspartate oxidase-deficient mice

被引:55
作者
Huang, AS
Beigneux, A
Weil, ZM
Kim, PM
Molliver, ME
Blackshaw, S
Nelson, RJ
Young, SG
Snyder, SH
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA
[5] Ohio State Univ, Dept Psychol, Inst Behav Med Res, Columbus, OH 43210 USA
[6] Ohio State Univ, Dept Neurosci, Inst Behav Med Res, Columbus, OH 43210 USA
关键词
amino acid; neuroendocrine; knock-out mice; aspartate; turnover; behavior; proopiomelanocortin (POMC);
D O I
10.1523/JNEUROSCI.5060-05.2006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
D-Aspartate, an abundant D-amino acid enriched in neuroendocrine tissues, can be degraded by D-aspartate oxidase (Ddo). To elucidate the function of D-aspartate, we generated mice with targeted deletion of Ddo (Ddo(-/-)) and observe massive but selective augmentations of D-aspartate in various tissues. The pituitary intermediate lobe, normally devoid of D-aspartate from endogenous Ddo expression, manifests pronounced increases of immunoreactive D-aspartate in Ddo(-/-) mice. Ddo(-/-) mice show markedly diminished synthesis and levels of pituitary proopiomelanocortin/alpha-MSH, associated with decreased melanocortin-dependent behaviors. Therefore, Ddo is the endogenous enzyme that degrades D-aspartate, and Ddo-enriched organs, low in D-aspartate, may represent areas of high turnover where D-aspartate may be physiologically important.
引用
收藏
页码:2814 / 2819
页数:6
相关论文
共 34 条
[1]   MONOSODIUM GLUTAMATE DOES NOT ALTER ACTH-INDUCED OR APOMORPHINE-INDUCED PENILE ERECTION AND YAWNING [J].
ARGIOLAS, A ;
MELIS, MR ;
FRATTA, W ;
MAURI, A ;
GESSA, GL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 26 (03) :503-507
[2]   PROTEIN HORMONES IN CEREBROSPINAL-FLUID - EVIDENCE FOR RETROGRADE TRANSPORT OF PROLACTIN FRON PITUITARY TO BRAIN IN MAN [J].
ASSIES, J ;
SCHELLEKENS, APM ;
TOUBER, JL .
CLINICAL ENDOCRINOLOGY, 1978, 8 (06) :487-491
[3]   THIAZOLIDINE-2-CARBOXYLATE DERIVATIVES FORMED FROM GLYOXYLATE AND L-CYSTEINE OR L-CYSTEINYLGLYCINE AS POSSIBLE PHYSIOLOGICAL SUBSTRATES FOR D-ASPARTATE OXIDASE [J].
BURNS, CL ;
MAIN, DE ;
BUCKTHAL, DJ ;
HAMILTON, GA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 125 (03) :1039-1045
[4]   A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse [J].
Butler, AA ;
Kesterson, RA ;
Khong, K ;
Cullen, MJ ;
Pelleymounter, MA ;
Dekoning, J ;
Baetscher, M ;
Cone, RD .
ENDOCRINOLOGY, 2000, 141 (09) :3518-3521
[5]   Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass [J].
Chen, AS ;
Marsh, DJ ;
Trumbauer, ME ;
Frazier, EG ;
Guan, XM ;
Yu, H ;
Rosenblum, CI ;
Vongs, A ;
Feng, Y ;
Cao, LH ;
Metzger, JM ;
Strack, AM ;
Camacho, RE ;
Mellin, TN ;
Nunes, CN ;
Min, W ;
Fisher, J ;
Gopal-Truter, S ;
MacIntyre, DE ;
Chen, HY ;
Van der Ploeg, LHT .
NATURE GENETICS, 2000, 26 (01) :97-102
[6]   The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis [J].
Cone, RD ;
Cowley, MA ;
Butler, AA ;
Fan, W ;
Marks, DL ;
Low, MJ .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (Suppl 5) :S63-S67
[7]   Occurrence and neuroendocrine role of D-aspartic acid and N-methyl-D-aspartic acid in Ciona intestinalis [J].
D'Aniello, A ;
Spinelli, P ;
De Simone, A ;
D'Aniello, S ;
Branno, M ;
Aniello, F ;
Fisher, GH ;
Di Fiore, MM ;
Rastogi, RK .
FEBS LETTERS, 2003, 552 (2-3) :193-198
[8]   RELATIONSHIPS BETWEEN ALPHA-MSH LEVELS IN BLOOD AND IN CEREBROSPINAL-FLUID [J].
DEROTTE, AA ;
BOUMAN, HJ ;
VANWIMERSMAGREIDANUS, TB .
BRAIN RESEARCH BULLETIN, 1980, 5 (04) :375-381
[9]   THE PRESENCE OF FREE D-ASPARTIC ACID IN RODENTS AND MAN [J].
DUNLOP, DS ;
NEIDLE, A ;
MCHALE, D ;
DUNLOP, DM ;
LAJTHA, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (01) :27-32
[10]   NEONATAL TREATMENT WITH MONOSODIUM GLUTAMATE DOES NOT ALTER GROOMING BEHAVIOR INDUCED BY NOVELTY OR ADRENOCORTICOTROPIC HORMONE [J].
DUNN, AJ ;
WEBSTER, EL ;
NEMEROFF, CB .
BEHAVIORAL AND NEURAL BIOLOGY, 1985, 44 (01) :80-89